These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26308581)

  • 1. Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy.
    Todd TW; Kokubu H; Miranda HC; Cortes CJ; La Spada AR; Lim J
    Elife; 2015 Aug; 4():e08493. PubMed ID: 26308581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
    Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
    Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy.
    Nihei Y; Ito D; Okada Y; Akamatsu W; Yagi T; Yoshizaki T; Okano H; Suzuki N
    J Biol Chem; 2013 Mar; 288(12):8043-8052. PubMed ID: 23364790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant androgen receptor induces neurite loss and senescence independently of ARE binding in a neuronal model of SBMA.
    Karliner J; Liu Y; Merry DE
    Proc Natl Acad Sci U S A; 2024 Jul; 121(29):e2321408121. PubMed ID: 38976730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome-mediated proteolysis of the polyglutamine-expanded androgen receptor is a late event in spinal and bulbar muscular atrophy (SBMA) pathogenesis.
    Heine EM; Berger TR; Pluciennik A; Orr CR; Zboray L; Merry DE
    J Biol Chem; 2015 May; 290(20):12572-84. PubMed ID: 25795778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p62/SQSTM1 differentially removes the toxic mutant androgen receptor via autophagy and inclusion formation in a spinal and bulbar muscular atrophy mouse model.
    Doi H; Adachi H; Katsuno M; Minamiyama M; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Qiang Q; Tanaka F; Yanagawa T; Warabi E; Ishii T; Sobue G
    J Neurosci; 2013 May; 33(18):7710-27. PubMed ID: 23637164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy.
    Gogia N; Ni L; Olmos V; Haidery F; Luttik K; Lim J
    Front Mol Neurosci; 2022; 15():931301. PubMed ID: 35726299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].
    Sobue G
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1193-5. PubMed ID: 11464455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.
    Katsuno M; Adachi H; Tanaka F; Sobue G
    J Mol Med (Berl); 2004 May; 82(5):298-307. PubMed ID: 15133611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
    Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
    Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell biological approaches to investigate polyglutamine-expanded AR metabolism.
    Cooper LJ; Merry DE
    Methods Mol Biol; 2013; 1017():241-53. PubMed ID: 23719921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet.
    Rocchi A; Milioto C; Parodi S; Armirotti A; Borgia D; Pellegrini M; Urciuolo A; Molon S; Morbidoni V; Marabita M; Romanello V; Gatto P; Blaauw B; Bonaldo P; Sambataro F; Robins DM; Lieberman AP; Sorarù G; Vergani L; Sandri M; Pennuto M
    Acta Neuropathol; 2016 Jul; 132(1):127-44. PubMed ID: 26971100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular-targeted therapy for spinal and bulbar muscular atrophy (SBMA)].
    Sobue G
    Rinsho Shinkeigaku; 2010 Nov; 50(11):839-41. PubMed ID: 21921465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.
    Renier KJ; Troxell-Smith SM; Johansen JA; Katsuno M; Adachi H; Sobue G; Chua JP; Sun Kim H; Lieberman AP; Breedlove SM; Jordan CL
    Endocrinology; 2014 Jul; 155(7):2624-34. PubMed ID: 24742193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel polyglutamine-expanded aggregation species in spinal and bulbar muscular atrophy.
    Berger TR; Montie HL; Jain P; Legleiter J; Merry DE
    Brain Res; 2015 Dec; 1628(Pt B):254-264. PubMed ID: 26453288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genistein, a natural product derived from soybeans, ameliorates polyglutamine-mediated motor neuron disease.
    Qiang Q; Adachi H; Huang Z; Jiang YM; Katsuno M; Minamiyama M; Doi H; Matsumoto S; Kondo N; Miyazaki Y; Iida M; Tohnai G; Sobue G
    J Neurochem; 2013 Jul; 126(1):122-30. PubMed ID: 23363377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHIP overexpression reduces mutant androgen receptor protein and ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model.
    Adachi H; Waza M; Tokui K; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
    J Neurosci; 2007 May; 27(19):5115-26. PubMed ID: 17494697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes.
    Milioto C; Malena A; Maino E; Polanco MJ; Marchioretti C; Borgia D; Pereira MG; Blaauw B; Lieberman AP; Venturini R; Plebani M; Sambataro F; Vergani L; Pegoraro E; Sorarù G; Pennuto M
    Sci Rep; 2017 Jan; 7():41046. PubMed ID: 28117338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human adipose-derived mesenchymal stem cells as a new model of spinal and bulbar muscular atrophy.
    Dossena M; Bedini G; Rusmini P; Giorgetti E; Canazza A; Tosetti V; Salsano E; Sagnelli A; Mariotti C; Gellera C; Navone SE; Marfia G; Alessandri G; Corsi F; Parati EA; Pareyson D; Poletti A
    PLoS One; 2014; 9(11):e112746. PubMed ID: 25392924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy.
    Scaramuzzino C; Casci I; Parodi S; Lievens PMJ; Polanco MJ; Milioto C; Chivet M; Monaghan J; Mishra A; Badders N; Aggarwal T; Grunseich C; Sambataro F; Basso M; Fackelmayer FO; Taylor JP; Pandey UB; Pennuto M
    Neuron; 2015 Jan; 85(1):88-100. PubMed ID: 25569348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.